• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA(miRNA)在高血压中的作用:发病机制与潜在治疗方法

MicroRNAs (miRNAs) role in hypertension: pathogenesis and promising therapeutics.

作者信息

Shaheen Nour, Shaheen Ahmed, Diab Rehab Adel, Desouki Mariam Tarek

机构信息

Faculty of Medicine, Alexandria University, Alexandria.

Faculty of Medicine, Al-Azhar University, Cairo.

出版信息

Ann Med Surg (Lond). 2023 Nov 16;86(1):319-328. doi: 10.1097/MS9.0000000000001498. eCollection 2024 Jan.

DOI:10.1097/MS9.0000000000001498
PMID:38222760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10783350/
Abstract

BACKGROUND

MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in regulating various cellular processes, including cell proliferation, differentiation, apoptosis, and disease development. Recent studies have highlighted the importance of miRNAs in the development and progression of essential hypertension, a common form of high blood pressure that affects millions of individuals worldwide. The molecular mechanisms by which miRNAs regulate hypertension are complex and multifaceted. MiRNAs target the 3' untranslated regions of mRNA molecules, thereby regulating the synthesis of specific proteins involved in cardiovascular function. For instance, miRNAs are known to regulate the expression of genes involved in blood vessel tone, cardiac function, and inflammation. The growing body of research on miRNAs in hypertension has highlighted their potential as therapeutic targets for managing this condition. Studies have shown that miRNA-based therapies can modulate the expression of key genes involved in hypertension, leading to improvements in blood pressure and cardiovascular function. However, more research is needed to fully understand the mechanisms of miRNA-mediated hypertension and to develop effective therapeutic strategies.

CONCLUSIONS

In summary, this review highlights the current understanding of the role of miRNAs in essential hypertension, including their molecular mechanisms and potential therapeutic applications. Further research is needed to fully understand the impact of miRNAs on hypertension and to develop new treatments for this common and debilitating condition.

摘要

背景

微小RNA(miRNA)是小的非编码RNA分子,在调节各种细胞过程中发挥关键作用,包括细胞增殖、分化、凋亡和疾病发展。最近的研究强调了miRNA在原发性高血压(一种影响全球数百万人的常见高血压形式)的发生和发展中的重要性。miRNA调节高血压的分子机制复杂且多方面。miRNA靶向mRNA分子的3'非翻译区,从而调节参与心血管功能的特定蛋白质的合成。例如,已知miRNA调节参与血管张力、心脏功能和炎症的基因的表达。关于高血压中miRNA的研究不断增加,突出了它们作为治疗这种疾病靶点的潜力。研究表明,基于miRNA的疗法可以调节参与高血压的关键基因的表达,从而改善血压和心血管功能。然而,需要更多的研究来充分了解miRNA介导的高血压机制并制定有效的治疗策略。

结论

总之,本综述强调了目前对miRNA在原发性高血压中的作用的理解,包括它们的分子机制和潜在的治疗应用。需要进一步研究以充分了解miRNA对高血压的影响,并为这种常见且使人衰弱的疾病开发新的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/52dfdffbbe14/ms9-86-319-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/1cec1756dd59/ms9-86-319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/2ce982202298/ms9-86-319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/337ebf05960a/ms9-86-319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/52dfdffbbe14/ms9-86-319-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/1cec1756dd59/ms9-86-319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/2ce982202298/ms9-86-319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/337ebf05960a/ms9-86-319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/10783350/52dfdffbbe14/ms9-86-319-g005.jpg

相似文献

1
MicroRNAs (miRNAs) role in hypertension: pathogenesis and promising therapeutics.微小RNA(miRNA)在高血压中的作用:发病机制与潜在治疗方法
Ann Med Surg (Lond). 2023 Nov 16;86(1):319-328. doi: 10.1097/MS9.0000000000001498. eCollection 2024 Jan.
2
MicroRNAs and Potential Targets in Osteosarcoma: Review.微小 RNA 与骨肉瘤的潜在靶点:综述。
Front Pediatr. 2015 Aug 24;3:69. doi: 10.3389/fped.2015.00069. eCollection 2015.
3
The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.微小RNA在心血管疾病发生、诊断及治疗中的作用:最新进展
J Pharmacol Exp Ther. 2023 Jan;384(1):123-132. doi: 10.1124/jpet.121.001152. Epub 2022 Jul 2.
4
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
5
Therapeutic evaluation of microRNAs by molecular imaging.通过分子成像进行 microRNAs 的治疗评估。
Theranostics. 2013 Dec 6;3(12):964-85. doi: 10.7150/thno.4928.
6
Mechanisms and therapeutic potential of microRNAs in hypertension.微小RNA在高血压中的作用机制及治疗潜力
Drug Discov Today. 2015 Oct;20(10):1188-204. doi: 10.1016/j.drudis.2015.05.007. Epub 2015 May 21.
7
MicroRNA and Cardiovascular Diseases.微小 RNA 与心血管疾病。
Balkan Med J. 2020 Feb 28;37(2):60-71. doi: 10.4274/balkanmedj.galenos.2020.2020.1.94. Epub 2020 Feb 5.
8
MicroRNA and Their Potential Role in Conjunctival Disorders.miRNA 及其在结膜疾病中的潜在作用。
Korean J Ophthalmol. 2022 Oct;36(5):452-462. doi: 10.3341/kjo.2022.0010. Epub 2022 Aug 19.
9
MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.微小RNA作为心血管疾病的候选药物靶点
Curr Drug Targets. 2017;18(4):463-472. doi: 10.2174/1389450117666160301101221.
10
MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.炎症性肠病中的 microRNAs-发病机制、诊断和治疗。
World J Gastroenterol. 2012 Sep 14;18(34):4629-34. doi: 10.3748/wjg.v18.i34.4629.

引用本文的文献

1
From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure.从利钠肽到微小RNA:心力衰竭中的多分析物液体活检前景
Biomolecules. 2025 Aug 19;15(8):1189. doi: 10.3390/biom15081189.
2
Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectives.探索源自植物外泌体样纳米颗粒(PELNs)的微小RNA的生物活性:当前观点
J Nanobiotechnology. 2025 Aug 12;23(1):563. doi: 10.1186/s12951-025-03602-9.
3
Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis.

本文引用的文献

1
Integrated Analysis of miRNA and mRNA Regulation Network in Hypertension.高血压 miRNA 和 mRNA 调控网络的综合分析。
Biochem Genet. 2023 Dec;61(6):2566-2579. doi: 10.1007/s10528-023-10389-7. Epub 2023 May 10.
2
MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling.microRNA-122-5p 通过调节 Elabela/ Apelin-APJ 和 ACE2-GDF15-Porimin 信号加重血管紧张素 II 介导的高血压大鼠心肌纤维化和功能障碍。
J Cardiovasc Transl Res. 2022 Jun;15(3):535-547. doi: 10.1007/s12265-022-10214-3. Epub 2022 Feb 16.
3
微小RNA在代谢综合征代谢因子簇中的作用:营养-基因组-代谢综合征轴
J Clin Med. 2025 Jun 14;14(12):4234. doi: 10.3390/jcm14124234.
4
Multiple system biology approaches reveals the role of the hsa-miR-21 in increasing risk of neurological disorders in patients suffering from hypertension.多种系统生物学方法揭示了hsa-miR-21在增加高血压患者患神经疾病风险中的作用。
J Hum Hypertens. 2025 May 20. doi: 10.1038/s41371-025-01027-3.
5
Extracellular Vesicles (EVs) Derived from Mesenchymal Stem Cells (MSCs) as Adjuvants in the Treatment of Chronic Kidney Disease (CKD).源自间充质干细胞(MSCs)的细胞外囊泡(EVs)作为慢性肾脏病(CKD)治疗中的佐剂
Cells. 2025 Mar 14;14(6):434. doi: 10.3390/cells14060434.
6
Effect of conditioned medium from miRNA-34a transfected gastric cancer-associated fibroblast on peripheral blood mononuclear cells.miRNA-34a转染的胃癌相关成纤维细胞条件培养基对外周血单个核细胞的影响
BMC Immunol. 2025 Feb 25;26(1):9. doi: 10.1186/s12865-025-00688-6.
7
Oxidative Stress in Kidney Injury and Hypertension.肾脏损伤与高血压中的氧化应激
Antioxidants (Basel). 2024 Nov 27;13(12):1454. doi: 10.3390/antiox13121454.
8
MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets.微小RNA在帕金森病中的调控及其作为诊断和治疗靶点的潜在作用。
NPJ Parkinsons Dis. 2024 Oct 5;10(1):186. doi: 10.1038/s41531-024-00791-2.
MicroRNAs Regulating Renin-Angiotensin-Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension.
微小 RNA 调控系统性动脉高血压中的肾素-血管紧张素-醛固酮系统、交感神经系统和左心室肥厚。
Biomolecules. 2021 Nov 26;11(12):1771. doi: 10.3390/biom11121771.
4
Correlation of circulating miRNA-33a and miRNA-122 with lipid metabolism among Egyptian patients with metabolic syndrome.埃及代谢综合征患者循环miRNA - 33a和miRNA - 122与脂质代谢的相关性
J Genet Eng Biotechnol. 2021 Oct 5;19(1):147. doi: 10.1186/s43141-021-00246-8.
5
miR-204: Molecular Regulation and Role in Cardiovascular and Renal Diseases.miR-204:分子调控及其在心血管和肾脏疾病中的作用。
Hypertension. 2021 Aug;78(2):270-281. doi: 10.1161/HYPERTENSIONAHA.121.14536. Epub 2021 Jun 28.
6
The role of microRNAs in cell death pathways.微小RNA在细胞死亡途径中的作用。
Yeungnam Univ J Med. 2021 Apr;38(2):107-117. doi: 10.12701/yujm.2020.00836. Epub 2021 Jan 13.
7
MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling.MicroRNA-122 通过调节 SIRT6-elabela-ACE2 信号加重血管紧张素 II 介导的大鼠主动脉外膜成纤维细胞凋亡和自噬失衡。
Eur J Pharmacol. 2020 Sep 15;883:173374. doi: 10.1016/j.ejphar.2020.173374. Epub 2020 Jul 16.
8
Mindfulness with paced breathing reduces blood pressure.有节奏呼吸的正念减压法可降低血压。
Med Hypotheses. 2020 Sep;142:109780. doi: 10.1016/j.mehy.2020.109780. Epub 2020 Apr 22.
9
The circulating level of miR-122 is a potential risk factor for endothelial dysfunction in young patients with essential hypertension.循环 miR-122 水平是原发性高血压青年患者内皮功能障碍的潜在危险因素。
Hypertens Res. 2020 Jun;43(6):511-517. doi: 10.1038/s41440-020-0405-5. Epub 2020 Feb 10.
10
Correlations Between Interleukin-11 Expression and Hypertensive Kidney Injury in a Rat Model of Renovascular Hypertension.白细胞介素-11 表达与肾血管性高血压大鼠模型中高血压肾损伤的相关性。
Am J Hypertens. 2020 Apr 1;33(4):331-340. doi: 10.1093/ajh/hpz194.